Israel Englander Finch Therapeutics Group, Inc. Transaction History

Millennium Management LLC

  • $224 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.34 - $0.56 $8,649 - $14,246
-25,441 Reduced 34.33%
48,669 $19,000
Q4 2022

Feb 14, 2023
SELL
$0.36 - $1.26 $16,846 - $58,964
-46,797 Reduced 38.7%
74,110 $36,000
Q3 2022

Nov 14, 2022
BUY
$1.75 - $2.88 $52,263 - $86,011
29,865 Added 32.8%
120,907 $202,000

About Finch Therapeutics Group, Inc.

FNCH Quotes by TradingView
  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $63.4M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email